Abiraterone Acetate
In Stock•Starting at $6 for 100 mg•Purity ≥ 98%
| CAS No. | 154229-18-2 |
|---|---|
| MDL No. | MFCD00934213 |
| MF | C26H33NO2 |
| MW | 391.50 |
| InChI Key | UVIQSJCZCSLXRZ-UBUQANBQSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 100 mg | 98% | $6 | In Stock | |
| 250 mg | 98% | $8 | In Stock | |
| 1 g | 98% | $13 | In Stock | |
| 5 g | 98% | $33 | In Stock | |
| 10 g | 98% | $60 | In Stock |
Product Information
Abiraterone acetate is a sterol ester formed by the condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. It functions as a prodrug that is converted in vivo to abiraterone. Used in the treatment of metastatic castrate-resistant prostate cancer. It acts as a prodrug, an antineoplastic agent, and an inhibitor of EC 1.14.99.9 (steroid 17alpha-monooxygenase). It is a sterol ester and a pyridine derivative, functionally related to abiraterone.
| CAS No. | 154229-18-2 |
|---|---|
| Product Name | Abiraterone Acetate |
Biological Targets
CYP17A1
Associated Conditions
cancer·congenital adrenal hyperplasia·metastatic prostate cancer·prostate carcinoma·salivary gland neoplasm·
* The information provided here is compiled from public sources and is for reference only.
